Evidence map›Paper›PMID 35730718›Full record

ArticleThe EMBO journal2022

Convergent dopamine and ALK4 signaling to PCBP1 controls FosB alternative splicing and cocaine behavioral sensitization.

Favio A Krapacher, Diana Fernández-Suárez, Annika Andersson, Alvaro Carrier-Ruiz, Carlos F Ibáñez

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Alternative splicing in addiction.Current opinion in genetics & development · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Favio A KrapacherDepartment of Neuroscience, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-8437-7061
Diana Fernández-SuárezDepartment of Neuroscience, Karolinska Institute, Stockholm, Sweden.
Annika AnderssonDepartment of Neuroscience, Karolinska Institute, Stockholm, Sweden.
Alvaro Carrier-RuizDepartment of Neuroscience, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-0889-709X
Carlos F IbáñezDepartment of Neuroscience, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0003-4090-0794
Karolinska Institutet · SEPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ΔfosB is an alternatively spliced product of the FosB gene that is essential for dopamine-induced reward pathways and that acts as a master switch for addiction. However, the molecular mechanisms of its generation and regulation by dopamine signaling are unknown. Here, we report that dopamine D1 receptor signaling synergizes with the activin/ALK4/Smad3 pathway to potentiate the generation of ΔFosB mRNA in medium spiny neurons (MSNs) of the nucleus accumbens (NAc) via activation of the RNA-binding protein PCBP1, a regulator of mRNA splicing. Concurrent activation of PCBP1 and Smad3 by D1 and ALK4 signaling induced their interaction, nuclear translocation, and binding to sequences in exon-4 and intron-4 of FosB mRNA. Ablation of either ALK4 or PCBP1 in MSNs impaired ΔFosB mRNA induction and nuclear translocation of ΔFosB protein in response to repeated co-stimulation of D1 and ALK4 receptors. Finally, ALK4 is required in NAc MSNs of adult mice for behavioral sensitization to cocaine. These findings uncover an unexpected mechanism for ΔFosB generation and drug-induced sensitization through convergent dopamine and ALK4 signaling.

Indexed as

CocaineActivin Receptors, Type IAlternative SplicingAnimalsDNA-Binding ProteinsDopamineMiceMice, Inbred C57BLNucleus AccumbensProto-Oncogene Proteins c-fosReceptors, Dopamine D1RNA-Binding ProteinsRNA, MessengerActivin Receptors, Type IAcvr1b protein, mouseCocaineDNA-Binding ProteinsDopamineFosb protein, mousePcbp1 protein, mouseProto-Oncogene Proteins c-fosReceptors, Dopamine D1RNA-Binding ProteinsRNA, Messengeractivinaddictiondrugs of abuse∆FosB

Identifiers

PMID35730718
PMCPMC10545536
OpenAlexW4283329362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.